According to Royalty Pharma's latest financial reports the company's total assets are $16.38 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $16.38 B | -2.57% |
2022-12-31 | $16.81 B | -4.01% |
2021-12-31 | $17.51 B | 9.34% |
2020-12-31 | $16.02 B | 28.68% |
2019-12-31 | $12.44 B | 9.5% |
2018-12-31 | $11.37 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | $73.21 B | 346.92% | ๐บ๐ธ USA |
Eli Lilly LLY | $64.00 B | 290.71% | ๐บ๐ธ USA |
ANI Pharmaceuticals ANIP | $0.90 B | -94.48% | ๐บ๐ธ USA |